Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations

被引:111
作者
Christiansen, C
Pichler, WJ
Skotland, T
机构
[1] Nycomed Imaging AS, Res & Dev, N-0401 Oslo, Norway
[2] Inselspital Bern, Inst Immunol & Allergol, CH-3010 Bern, Switzerland
关键词
X-ray contrast media; allergy-like reactions; delayed reactions; pathophysiological mechanisms;
D O I
10.1007/s003300000543
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Iodinated X-ray contrast media are among the most frequently used pharmaceuticals for intravascular administration. Although the newer low osmolality, nonionic contrast media, are generally well tolerated it is well known that they, like the ionic contrast. give rise to immediate or delayed adverse reactions in susceptible individuals. In the present review delayed allergy-like reactions, which by definition occur more than 1 h after contrast medium administration ,are described, and the possible patho-physiological mechanisms discussed. Delayed allergy-like reactions to contrast media which have been media, which have been reported to occur in 0.5-2 % of recipients, are mainly mild to modern skin reactions of the maculopapular exanthematous and urticaril/angioedematous types. Most of the reactions become apparent after a latency of 3 h to 2 days and dissappear within 1 week. The incidence of more severe reactions is extremely low. Main risk factors for delayed allergy-like reactions appear to be a previous contrast medium reaction, a history of allergy, IL-2 treatment and being of Japanese descent. At present, the exact pathogenesis of these delayed reactions is still unclear. There is, however, increasing evidence that a significant proportion of the reactions are T- cell mediated.
引用
收藏
页码:1965 / 1975
页数:11
相关论文
共 95 条
  • [1] METASTATIC RENAL-CELL CANCER - INTERLEUKIN-2 TOXICITY INDUCED BY CONTRAST AGENT INJECTION
    ABIAAD, AS
    FIGLIN, RA
    BELLDEGRUN, A
    DEKERNION, JB
    [J]. JOURNAL OF IMMUNOTHERAPY, 1991, 10 (04): : 292 - 295
  • [2] Drug eruption caused by nonionic iodinated X-ray contrast media
    Akiyama, M
    Nakada, T
    Sueki, H
    Fujisawa, R
    Iijima, M
    [J]. ACADEMIC RADIOLOGY, 1998, 5 : S159 - S161
  • [3] Visipaque - A step forward - A historical review
    Almen, T
    [J]. ACTA RADIOLOGICA, 1995, 36 : 2 - 18
  • [4] Asano S, 1990, Rinsho Hoshasen, V35, P533
  • [5] Barbaud A, 1997, EUR J DERMATOL, V7, P319
  • [6] Adverse events with radiographic contrast agents: Results of the SCVIR Contrast Agent Registry
    Bettmann, MA
    Heeren, T
    Greenfield, A
    Goudey, C
    [J]. RADIOLOGY, 1997, 203 (03) : 611 - 620
  • [7] BEYERENKE SA, 1993, EUR RADIOL, V3, P237
  • [8] BIGBY M, 1986, JAMA-J AM MED ASSOC, V256, P3358
  • [9] Borofsky H., 1993, ADV XRAY CONTRAST, V1, P58
  • [10] An overview of the clinical pharmacokinetics of x-ray contrast media
    Bourin, M
    Jolliet, P
    Ballereau, F
    [J]. CLINICAL PHARMACOKINETICS, 1997, 32 (03) : 180 - 193